First Time Loading...

Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 39.15 CNY 1.16% Market Closed
Updated: May 14, 2024

Tibet Rhodiola Pharmaceutical Holding Co
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tibet Rhodiola Pharmaceutical Holding Co
EPS (Diluted) Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
EPS (Diluted)
¥3
CAGR 3-Years
24%
CAGR 5-Years
30%
CAGR 10-Years
37%
Sinopharm Group Co Ltd
HKEX:1099
EPS (Diluted)
¥2
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
13%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
EPS (Diluted)
¥1
CAGR 3-Years
-14%
CAGR 5-Years
-6%
CAGR 10-Years
2%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
EPS (Diluted)
¥0
CAGR 3-Years
-31%
CAGR 5-Years
-3%
CAGR 10-Years
5%
C
China National Medicines Corp Ltd
SSE:600511
EPS (Diluted)
¥2
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
13%
Huadong Medicine Co Ltd
SZSE:000963
EPS (Diluted)
¥1
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
16%

See Also

What is Tibet Rhodiola Pharmaceutical Holding Co's EPS (Diluted)?
EPS (Diluted)
3.2 CNY

Based on the financial report for Dec 31, 2023, Tibet Rhodiola Pharmaceutical Holding Co's EPS (Diluted) amounts to 3.2 CNY.

What is Tibet Rhodiola Pharmaceutical Holding Co's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
37%

Over the last year, the EPS (Diluted) growth was 117%. The average annual EPS (Diluted) growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 24% over the past three years , 30% over the past five years , and 37% over the past ten years .